ARTICLE | Company News
Dynavax other research news
January 17, 2005 8:00 AM UTC
DVAX announced that the Alliance for Lupus Research (ALR) awarded a $500,000 grant to explore new treatment approaches for SLE based on DVAX's novel immunoregulatory sequences (IRS) technology. IRS in...